ARCHIVES

Amgen Claimed QOL Benefit Despite FDA Label Change.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Questions Raised By Committee Kills Still Not Resolved

July 29, 1977

Tobacco Money Placed In Non-Profit Run By Henschke, Weill Cornell Officials.

March 28, 2008

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009